NOVELTY - An isolated polynucleotide selected from: (a) a polynucleotide comprising nucleic acid sequence; (b) a polynucleotide encoding a polypeptide; (c) a polynucleotide hybridizing under stringent conditions to the polynucleotide of (a) or (b); and (d) a polynucleotide hybridizing under stringent conditions to the reverse complement of the polynucleotide of (a) or (b), is new.    USE - The isolated polynucleotide is useful for manufacturing a polypeptide, where the polypeptide is useful for prebleaching kraft pulp; for processing lignin; for producing ethanol; for treating textiles or dyed textiles; for degrading biomass or pretreated biomass; and in the manufacture of a detergent (all claimed).    ADVANTAGE - The isolated polynucleotide encodes novel cell wall deconstruction enzymes, and efficiently produces polypeptide used in degrading biomass or pretreated biomass.    DETAILED DESCRIPTION - An isolated polynucleotide selected from: (a) a polynucleotide comprising nucleic acid sequence as set forth in any one of SEQ ID NOS: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 55, 56, 58, 59, 61, 62, 64, 65, 67, 68, 70, 71, 73, 74, 76, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 95, 97, 98, 100, 101, 103, 104, 106, 107, 109, 110, 112, 113, 115, 116, 118, 119, 121, 122, 124, 125, 127, 128, 130, 131, 133, 134, 136, 137, 139, 140, 142, and 143, sequences not defined here may be found at ftp://ftp.wipo.int/pub/published_pct_sequences/publication, or a functional equivalent; (b) a polynucleotide encoding a polypeptide comprising a polypeptide sequence as set forth in any one of SEQ ID NOS: 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60, 63, 66, 69, 72, 75, 78, 81, 84, 87, 90, 93, 96, 99, 102, 105, 108, 111, 114, 117, 120, 123, 126, 129, 132, 135, 138, 141, and 144, sequences not defined here may be found at ftp://ftp.wipo.int/pub/published_pct_sequences/publication, or a functional equivalent; (c) a polynucleotide hybridizing under stringent conditions to the polynucleotide of (a) or (b); and (d) a polynucleotide hybridizing under stringent conditions to the reverse complement of the polynucleotide of (a) or (b), is new. INDEPENDENT CLAIMS are:    (1) a vector comprising the polynucleotide;    (2) a host cell comprising the polynucleotide or the vector;    (3) an isolated polypeptide: (a) as set forth in any one of SEQ ID NOS: 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60, 63, 66, 69, 72, 75, 78, 81, 84, 87, 90, 93, 96, 99, 102, 105, 108, 111, 114, 117, 120, 123, 126, 129, 132, 135, 138, 141, and 144, or a functional equivalent; (b) that is at least 60-99% homologous to the any one of SEQ ID NOS: 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60, 63, 66, 69, 72, 75, 78, 81, 84, 87, 90, 93, 96, 99, 102, 105, 108, 111, 114, 117, 120, 123, 126, 129, 132, 135, 138, 141, and 144; (c) having a sequence encoded by nucleic acid sequence as set forth in any one of SEQ ID NOS: 1, 2, 4, 5,7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 55, 56, 58, 59, 61, 62, 64, 65, 67, 68, 70, 71, 73, 74, 76, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 95, 97, 98, 100, 101, 103, 104, 106, 107, 109, 110, 112, 113, 115, 116, 118, 119, 121, 122, 124, 125, 127, 128, 130, 131, 133, 134, 136, 137, 139, 140, 142, and 143, or nucleic acids that are at least 60-99% homologous to any one of the nucleic acid sequence; (d) having a sequence encoded by a nucleic acid sequence hybridizing under stringent conditions to the polynucleotide as set forth in any one of SEQ ID NOS: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 55, 56, 58, 59, 61, 62, 64, 65, 67, 68, 70, 71, 73, 74, 76, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 95, 97, 98, 100, 101, 103, 104, 106, 107, 109, 110, 112, 113, 115, 116, 118, 119, 121, 122, 124, 125, 127, 128, 130, 131, 133, 134, 136, 137, 139, 140, 142, and 143; or (e) having a sequence encoded by a nucleic acid sequence hybridizing under stringent conditions to the reverse complement of a polynucleotide as set forth in any one of SEQ ID NOS: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 55, 56, 58, 59, 61, 62, 64, 65, 67, 68, 70, 71, 73, 74, 76, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 95, 97, 98, 100, 101, 103, 104, 106, 107, 109, 110, 112, 113, 115, 116, 118, 119, 121, 122, 124, 125, 127, 128, 130, 131, 133, 134, 136, 137, 139, 140, 142, and 143; and    (4) a method for manufacturing the polypeptide, comprising: transforming a suitable host cell with an isolated polynucleotide or the vector; culturing the cell under conditions allowing expression of the polynucleotide; and optionally purifying the encoded polypeptide from the cell or culture medium.